0
Editorial |

Dynamics of Antibiotic Prescribing for Children

Michael E. Pichichero, MD
JAMA. 2002;287(23):3133-3135. doi:10.1001/jama.287.23.3133
Text Size: A A A
Published online

The dynamics that influence antibiotic prescribing by office-based physicians in the United States are complex. Physicians have been receiving repeated messages to curtail antibiotic use from the biomedical literature, medical and public media, health insurance companies, key opinion leaders, alternative medicine advocates, and some patients. The message has been consistent, frequent, and loud, so it cannot have been missed. The crescendo of research during the past decade has established that (1) antibiotic overuse is a major public health problem1 ; (2) approximately 50% of prescriptions for children written by community-based practitioners are unnecessary,2 and (3) the single most important factor in the emergence of antibiotic resistance among respiratory bacterial pathogens is selection pressure from antimicrobial agents.3 Thus, as a public health policy, there seems little doubt that overzealous prescribing habits and inappropriate use of antibiotics should be reduced on a community-wide basis.

This all sounds good, but what about the individual patient seeking care? Faced with an ill-appearing, febrile child or adolescent, anxious parents, a busy office schedule, a potential insurance company audit of medical records, and the omnipresent concern for malpractice litigation, the physician must consider a different dynamic. Considerations when making treatment decisions for the individual patient include diagnostic uncertainty; sociocultural and economic pressures; meeting parent/patient and insurance company expectations; and taking defensive action in case of litigation.4 Occasionally, some bacterial infections that are preceded by viral illness have a rapid course, and patients may not always return to see the physician if the illness worsens or persists. Thus, the inclination is to err on the side of prescribing antibiotics even if the chance of a bacterial infection is low. The perceived risk for the individual patient to have an illness evolve with significant consequences often seems more important than the risks of dealing with an antibiotic-resistant organism later.4

In this issue of THE JOURNAL, McCaig and colleagues5 assess trends in antibiotic prescribing from 1989-1990 through 1999-2000 for US children and adolescents younger than 15 years. The authors used data from standardized office visit record forms completed by nationally representative samples of office-based physicians, who participated in annual National Ambulatory Medical Care Surveys (NAMCSs), to calculate population- and visit-based antibiotic prescribing rates. This study is a follow-up to a prior analysis of NAMCS data,6 which demonstrated increasing annual population-based rates of antibiotic prescribing in outpatient settings for pediatric patients from 1980 through 1992. The take-home message of the current study is that antibiotic prescribing appears to have decreased overall and for common respiratory tract infections among children. That is good news, if true.

Several factors other than appropriate use, however, might explain the observed decline in antibiotic prescribing. Some of the decline might be accounted for by a decreasing secular trend in physician visits over the study period. Perhaps the worried well and patients with milder illness are simply not visiting physicians as often. The NAMCS only captures drugs dispensed at a physician visit, so if physician visits decline, antibiotic prescriptions will decline at a population level. Visit-based rates, however, which do not depend on the number of office visits, also declined overall and for respiratory tract infections. Increased telephone dispensing of antibiotics might be another variable to explain the observed trends. McCaig et al used urinary tract infections as an indicator condition for changes in telephone prescribing. However, physicians might regard urinary tract infections quite differently than respiratory tract infections in terms of the need for in-office evaluations. The pattern of care and use of telephone triage for respiratory tract infections may not be the same as for urinary tract infections. Patient self-administration of leftover antibiotic prescriptions might also be occurring. One study suggests that up to 66% of children arriving for outpatient care have already been self-administering antibiotics.7

For otitis media and bronchitis, McCaig et al noted decreases in the population-based antibiotic prescribing rate, but not in the visit-based prescribing rate. The authors speculate that only patients with more serious infections came to physician offices; that diagnosis may have been more accurate; or that the incidence of otitis media and bronchitis may have decreased with no change in prescribing practices. However, there is no evidence to suggest that parents are waiting until their child appears to have a more serious illness before seeking care. The notion that diagnostic accuracy has improved also could be questioned. A recent study suggests that pediatricians have a poor knowledge about pneumatic otoscopy and misdiagnose otitis media about 50% of the time.8 With interactive continuing medical education instruction, sustained changes in otitis media diagnosis and an associated reduction in antibiotic use may occur.9 The possibility that the incidence of bronchitis may have decreased seems plausible because more bronchitis may be recognized as asthma.

Because of the considerable attention focused on antibiotic overprescribing, physicians may be changing their diagnostic labeling depending on whether they intend to prescribe antibiotics. For example, if a physician intends to treat a patient with a cough illness with antibiotics, the diagnosis might be recorded as bronchopneumonia or Mycoplasma pneumoniae, whereas if antibiotics are not prescribed, the diagnosis of bronchitis might be used. For a child with an upper respiratory tract infection, fever, loss of appetite, ear tugging, and a poor night of sleep, the physician might record a diagnosis of otitis media when antibiotics are prescribed, whereas the diagnosis of upper respiratory tract infection or otalgia might be used if antibiotics are not prescribed. To assess the possibility of diagnosis shifting, McCaig and colleagues analyzed prescribing for a combination of respiratory tract infection visit diagnoses. It is reassuring that the authors still found a significant overall decline in antibiotic prescriptions.

Another methodologic concern relates to the veracity of reporting antibiotic prescriptions. The numerous publications and public information campaigns by the Centers for Disease Control and Prevention, the American Academy of Pediatricians, American Academy of Family Physicians, and other professional organizations might have heightened awareness of criticism regarding excessive antibiotic use. As a consequence, physicians may have changed their behavior or they simply may have changed their responses to the NAMCS. In a recent Centers for Disease Control and Prevention study of pediatricians and family physicians, wide differences between survey responses regarding adherence to diagnostic criteria and treatment guidelines and actual antibiotic prescribing practice as determined by chart review were found for pediatric respiratory tract infections.10 For this concern, there are no remedies for NAMCS data because no reabstraction studies have been performed to determine the validity of NAMCS responses.

In this issue of THE JOURNAL, an accompanying article by Perz at al11 allays some of the concerns inherent in interpretation of survey data and corroborates the secular trend for declining use of antibiotics. The investigators assessed the impact of a community-wide education campaign in Knox County, Tennessee, designed to reduce unnecessary antibiotic use. They compared trends in antibiotic prescribing rates among Medicaid recipients younger than 15 years in Knox County with those in 3 other (control) counties in Tennessee before, during, and after the education intervention. This commendable effort was associated with an overall 11% intervention-attributable decline in antibiotic prescription rates, although in a much smaller population than that studied by McCaig et al. This decline in antibiotic prescribing is within the expected range based on other intervention studies.12 - 15 Also, because Perz et al used the excess percentage change in antimicrobial prescription rates in Knox County before and after the intervention relative to control counties as the primary outcome of their trial, prescriptions were not linked to specific office visits or diagnoses, avoiding issues of diagnosis shifting and telephone prescribing.

Several limitations of the study by Perz et al should be considered. Only 4 counties in Tennessee were studied, and their nonrandom assignment increases the potential for bias. Some sources of bias could be identified (such as racial distribution) and controlled for in the analysis, but other unrecognized sources for bias may exist (eg, differences in media exposure regarding antibiotic use). The study used available data for health care services provided to a low-income population that may not be applicable to the general population. Because baseline prescribing rates were substantially higher in Knox County compared with control counties, even after stratifying for race, regression to the mean could have contributed to the observed reduction in prescription rates. Lastly, the International Classification of Diseases, Ninth Revision, Clinical Modification codes used for respiratory tract infections did not include the code for streptococcal sore throat (034.0), and cases of pharyngitis that might have been given this code would not have been included in the analysis.

Despite the apparent decline in antibiotic prescribing for children and adolescents described by McCaig et al and Perz et al, resistance among bacteria that cause respiratory tract infections continues to increase.16 Mathematical models of the epidemiology and population genetics of antibiotic treatment and resistance in open and closed communities have explored (1) the relationship between antibiotic consumption and the frequency of antibiotic resistance in bacterial populations, (2) methods of controlling increases in the development of bacterial resistance, (3) dissemination and persistence of antibiotic resistance in these settings, (4) the extent to which development of resistance can be controlled, and (5) the speed with which the effects of control measures might be realized.17 These models predict that in open communities, it would take years or even decades to see substantial reductions in the frequency of antibiotic resistance solely as a result of more prudent use of antibiotics.

To achieve more selective, appropriate use of antibiotics for pediatric patients, several key clinical points should be emphasized. First, physicians need to learn to differentiate by otoscopic examination acute suppurative otitis media (for which antibiotics are appropriate) and otitis media with effusion (for which antibiotics may be deferred).18 - 19 Second, for patients with pharyngitis, laboratory documentation by rapid antigen detection test or throat culture for group A streptococcus should be a standard of care before antibiotics are prescribed.20 - 21 Third, upper respiratory tract infections are viral, and unless associated fever lasts more than 5 days22 or purulent rhinitis (which can be caused by a viral, allergic, or bacterial etiology) lasts more than 10 days,22 it would be prudent and preferable to postpone initiation of antibiotic therapy. Fourth, cough is usually caused by viral illness, and unless associated fever lasts more than 5 days23 or purulent sputum (which can be caused by a viral, allergic, or bacterial etiology) lasts more than 10 days23 or there are physical examination and/or chest radiograph findings providing evidence of pulmonary consolidation, it would be prudent and preferable to postpone initiation of antibiotics. Fifth, rhinosinusitis does not occur in all patients who complain of purulent nasal discharge and cough. The diagnosis of rhinosinusitis generally should not be made until such symptoms persist beyond 10 days.24 Finally, low dosages of antibiotics (as prescribed by physicians or taken by patients as self-medication from leftover supplies) promote bacterial resistance.25 Higher adequate doses26 for shorter time intervals27 are preferred for most patients with bacterial respiratory tract infections treated with antibiotics in the ambulatory care setting.

In summary, the studies by McCaig et al and Perz et al provide hope that inappropriate and excessive use of antibiotics to treat children with respiratory tract infections is declining. To continue this trend, physicians need to be convinced that presumptive antibiotic use for viral respiratory tract infections does not minimize or prevent the development of secondary bacterial infections4 ; that patients receiving presumptive antibiotics have no difference in rate of return visits28 ; that overuse of antibiotics promotes the development of bacterial resistance; that adverse effects of antibiotics can occur and may be serious; and that costs for unnecessary antibiotics should be avoided.4 Physicians want to do the right thing for their patients. Faced with an ill child or adolescent and worried parents, most often the right thing is reassurance, symptomatic therapy, and availability for follow-up—not antibiotics.

REFERENCES

Schwartz B, Bell DM, Hughes JM. Preventing the emergence of antimicrobial resistance.  JAMA.1997;278:944-945.
Nyquist AC, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis.  JAMA.1998;279:875-877.
Baquero F, Negri MC, Morosini MI, Blazquez J. Antibiotic selective environments.  Clin Infect Dis.1998;27(suppl 1):S5-S11.
Pichichero ME. Understanding antibiotic overuse for respiratory tract infections in children.  Pediatrics.1999;104:1384-1388.
McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents.  JAMA.2002;287:3096-3102.
McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States.  JAMA.1995;273:214-219.
Liu YC, Huang WK, Huang TS, Kunin CM. Extent of antibiotic use in Taiwan shown by antimicrobial activity in urine.  Lancet.1999;354:1360.
Pichichero ME, Poole MD. Assessing diagnostic accuracy and tympanocentesis skills in the management of otitis media.  Arch Pediatr Adolesc Med.2001;155:1137-1142.
Pichichero ME. A physician education intervention influenced prescribing for otitis media.  J Managed Care Pharm.2002;8:141-145.
Watson RL, Dowell SF, Jayaraman M.  et al.  Antimicrobial use for pediatric upper respiratory infections.  Pediatrics.1999;104:1251-1257.
Perz JF, Craig AS, Coffey CS.  et al.  Changes in antibiotic prescribing for children after a community-wide campaign.  JAMA.2002;287:3103-3109.
Seppala H, Klaukka T, Vuopio-Varikila J.  et al.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland.  N Engl J Med.1997;337:441-446.
Stephenson J. Icelandic researchers are showing the way to bring down rates of antibiotic-resistant bacteria.  JAMA.1996;275:175.
Belongia EA, Sullivan BJ, Chyou PH, Madagame E, Reed KD, Schwartz B. A community intervention trial to promote judicious antibiotic use and reduce penicillin-resistant Streptococcus pneumoniae carriage in children.  Pediatrics.2001;108:575-583.
Finkelstein JA, Davis RL, Dowell SF.  et al.  Reducing antibiotic use in children: a randomized trial in 12 practices.  Pediatrics.2001;108:1-7.
Doern GV, Heilmann KP, Huynh HK.  et al.  Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995.  Antimicrob Agents Chemother.2001;45:1721-1729.
Levin BR. Minimizing potential resistance: a population dynamics view.  Clin Infect Dis.2001;33(suppl 3):S161-S169.
Stool SE, Berg AO, Berman S.  et al.  Otitis media with effusion in young children. In: Clinical Practice Guideline No. 12. Rockville, Md: Agency for Health Care Policy and Research; 1994. Publication No. 94-0622.
Dowell SF, Marcy SM, Phillips WR.  et al.  Otitis media: principles of judicious use of antimicrobial agents.  Pediatrics.1998;101(suppl):165-170.
Dajani A, Taubert K, Ferrieri P.  et al.  Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever.  Pediatrics.1995;96:758-764.
Schwartz B, Marcy SM, Phillips WR, Gerber MA, Dowell SF. Pharyngitis: principles of judicious use of antimicrobial agents.  Pediatrics.1998;101(suppl):171-174.
Rosenstein N, Phillips WR, Gerber MA.  et al.  The common cold: principles of judicious use of antimicrobial agents.  Pediatrics.1998;101(suppl):181-184.
O'Brien KL, Dowell SF, Schwartz B, Marcy SM, Phillips WR, Gerber MA. Cough illness/bronchitis.  Pediatrics.1998;101(suppl):178-181.
O'Brien KL, Dowell SF, Schwartz B, Marcy SM, Phillips WR, Gerber MA. Acute sinusitis.  Pediatrics.1998;101(suppl):174-177.
Guillemot D, Carbon C, Balkau B.  et al.  Low dosage and long treatment duration of β-lactam.  JAMA.1998;279:365-370.
Schrag SJ, Pena C, Fernandez J.  et al.  Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage.  JAMA.2001;286:49-56.
Pichichero ME. Short course antibiotic therapy for respiratory infections: a review of the evidence.  Pediatr Infect Dis J.2000;19:929-937.
Pichichero ME, Green JL, Francis AB, Marsocci SM, Murphy ML. Outcomes after judicious antibiotic use for respiratory tract infections seen in a private pediatric practice.  Pediatrics.2000;105:1-7.

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Schwartz B, Bell DM, Hughes JM. Preventing the emergence of antimicrobial resistance.  JAMA.1997;278:944-945.
Nyquist AC, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis.  JAMA.1998;279:875-877.
Baquero F, Negri MC, Morosini MI, Blazquez J. Antibiotic selective environments.  Clin Infect Dis.1998;27(suppl 1):S5-S11.
Pichichero ME. Understanding antibiotic overuse for respiratory tract infections in children.  Pediatrics.1999;104:1384-1388.
McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents.  JAMA.2002;287:3096-3102.
McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States.  JAMA.1995;273:214-219.
Liu YC, Huang WK, Huang TS, Kunin CM. Extent of antibiotic use in Taiwan shown by antimicrobial activity in urine.  Lancet.1999;354:1360.
Pichichero ME, Poole MD. Assessing diagnostic accuracy and tympanocentesis skills in the management of otitis media.  Arch Pediatr Adolesc Med.2001;155:1137-1142.
Pichichero ME. A physician education intervention influenced prescribing for otitis media.  J Managed Care Pharm.2002;8:141-145.
Watson RL, Dowell SF, Jayaraman M.  et al.  Antimicrobial use for pediatric upper respiratory infections.  Pediatrics.1999;104:1251-1257.
Perz JF, Craig AS, Coffey CS.  et al.  Changes in antibiotic prescribing for children after a community-wide campaign.  JAMA.2002;287:3103-3109.
Seppala H, Klaukka T, Vuopio-Varikila J.  et al.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland.  N Engl J Med.1997;337:441-446.
Stephenson J. Icelandic researchers are showing the way to bring down rates of antibiotic-resistant bacteria.  JAMA.1996;275:175.
Belongia EA, Sullivan BJ, Chyou PH, Madagame E, Reed KD, Schwartz B. A community intervention trial to promote judicious antibiotic use and reduce penicillin-resistant Streptococcus pneumoniae carriage in children.  Pediatrics.2001;108:575-583.
Finkelstein JA, Davis RL, Dowell SF.  et al.  Reducing antibiotic use in children: a randomized trial in 12 practices.  Pediatrics.2001;108:1-7.
Doern GV, Heilmann KP, Huynh HK.  et al.  Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995.  Antimicrob Agents Chemother.2001;45:1721-1729.
Levin BR. Minimizing potential resistance: a population dynamics view.  Clin Infect Dis.2001;33(suppl 3):S161-S169.
Stool SE, Berg AO, Berman S.  et al.  Otitis media with effusion in young children. In: Clinical Practice Guideline No. 12. Rockville, Md: Agency for Health Care Policy and Research; 1994. Publication No. 94-0622.
Dowell SF, Marcy SM, Phillips WR.  et al.  Otitis media: principles of judicious use of antimicrobial agents.  Pediatrics.1998;101(suppl):165-170.
Dajani A, Taubert K, Ferrieri P.  et al.  Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever.  Pediatrics.1995;96:758-764.
Schwartz B, Marcy SM, Phillips WR, Gerber MA, Dowell SF. Pharyngitis: principles of judicious use of antimicrobial agents.  Pediatrics.1998;101(suppl):171-174.
Rosenstein N, Phillips WR, Gerber MA.  et al.  The common cold: principles of judicious use of antimicrobial agents.  Pediatrics.1998;101(suppl):181-184.
O'Brien KL, Dowell SF, Schwartz B, Marcy SM, Phillips WR, Gerber MA. Cough illness/bronchitis.  Pediatrics.1998;101(suppl):178-181.
O'Brien KL, Dowell SF, Schwartz B, Marcy SM, Phillips WR, Gerber MA. Acute sinusitis.  Pediatrics.1998;101(suppl):174-177.
Guillemot D, Carbon C, Balkau B.  et al.  Low dosage and long treatment duration of β-lactam.  JAMA.1998;279:365-370.
Schrag SJ, Pena C, Fernandez J.  et al.  Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage.  JAMA.2001;286:49-56.
Pichichero ME. Short course antibiotic therapy for respiratory infections: a review of the evidence.  Pediatr Infect Dis J.2000;19:929-937.
Pichichero ME, Green JL, Francis AB, Marsocci SM, Murphy ML. Outcomes after judicious antibiotic use for respiratory tract infections seen in a private pediatric practice.  Pediatrics.2000;105:1-7.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
JAMAevidence.com

Users' Guides to the Medical Literature
Clinical Resolution

Users' Guides to the Medical Literature
Clinical Scenario